{"parse":{"title":"Breakthrough therapy","pageid":45597229,"revid":848731119,"text":{"*":"<div class=\"mw-parser-output\"><p>\n<b>Breakthrough therapy</b> is a United States <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> designation that expedites drug development that was created by Congress under Section 902 of the 9 July 2012 <a href=\"/wiki/Food_and_Drug_Administration_Safety_and_Innovation_Act\" title=\"Food and Drug Administration Safety and Innovation Act\">Food and Drug Administration Safety and Innovation Act</a>.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup> The FDA's \"breakthrough therapy\" designation is not intended to imply that a drug is actually a \"breakthrough\" or that there is high-quality evidence of treatment efficacy for a particular condition;<sup id=\"cite_ref-healthnews_3-0\" class=\"reference\"><a href=\"#cite_note-healthnews-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-pmid25713472_4-0\" class=\"reference\"><a href=\"#cite_note-pmid25713472-4\">&#91;4&#93;</a></sup> rather, it allows the FDA to grant <a href=\"/wiki/Priority_review_(FDA)\" class=\"mw-redirect\" title=\"Priority review (FDA)\">priority review</a> to drug candidates if preliminary <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">clinical trials</a> indicate that the therapy may offer substantial treatment advantages over existing options for patients with serious or life-threatening diseases.<sup id=\"cite_ref-pmid25713472_4-1\" class=\"reference\"><a href=\"#cite_note-pmid25713472-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-FDA_2012_5-0\" class=\"reference\"><a href=\"#cite_note-FDA_2012-5\">&#91;5&#93;</a></sup> The FDA has other mechanisms for expediting the review and approval process for promising drugs, including <a href=\"/wiki/Fast_track_(FDA)\" title=\"Fast track (FDA)\">fast track</a> designation, <a href=\"/wiki/Accelerated_approval_(FDA)\" title=\"Accelerated approval (FDA)\">accelerated approval</a>, and <a href=\"/wiki/Priority_review_(FDA)\" class=\"mw-redirect\" title=\"Priority review (FDA)\">priority review</a>.<sup id=\"cite_ref-pmid25713472_4-2\" class=\"reference\"><a href=\"#cite_note-pmid25713472-4\">&#91;4&#93;</a></sup><sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Requirements\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Requirements</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Incentives\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Incentives</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Issues\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Issues</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Requirements\">Requirements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Breakthrough_therapy&amp;action=edit&amp;section=1\" title=\"Edit section: Requirements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A breakthrough therapy designation can be assigned to a drug if \"it is a drug which is intended alone or in <a href=\"/wiki/Combination_therapy\" title=\"Combination therapy\">combination</a> with one or more other drugs to treat a serious or life threatening disease or condition\" and if the <a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">preliminary clinical evidence</a> indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.\"<sup id=\"cite_ref-FDA_2012_5-1\" class=\"reference\"><a href=\"#cite_note-FDA_2012-5\">&#91;5&#93;</a></sup><sup id=\"cite_ref-FDASIA_2015_7-0\" class=\"reference\"><a href=\"#cite_note-FDASIA_2015-7\">&#91;7&#93;</a></sup>\n</p><p>Requests are reviewed by the <a href=\"/wiki/Center_for_Drug_Evaluation_and_Research\" title=\"Center for Drug Evaluation and Research\">Center for Drug Evaluation and Research</a> (CDER) and the <a href=\"/wiki/Center_for_Biologics_Evaluation_and_Research\" title=\"Center for Biologics Evaluation and Research\">Center for Biologics Evaluation and Research</a> (CBER). CDER receives approximately 100 requests per year for breakthrough designation. Historically, about one third were approved. CBER receives 15\u201330 requests per year.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> Sponsors must apply for breakthrough status separately for each indication they intend to label the drug for.\n</p><p>Breakthrough designation applications are submitted as an amendment to the <a href=\"/wiki/Investigational_new_drug\" class=\"mw-redirect\" title=\"Investigational new drug\">IND</a> applications before the initiation of clinical trials.<sup id=\"cite_ref-fda.gov_9-0\" class=\"reference\"><a href=\"#cite_note-fda.gov-9\">&#91;9&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Incentives\">Incentives</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Breakthrough_therapy&amp;action=edit&amp;section=2\" title=\"Edit section: Incentives\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Drugs that have been granted breakthrough status are given priority review. The FDA works with the sponsor of the drug application to expedite the approval process. This expedited process can include rolling reviews, smaller clinical trials, and alternative trial designs.<sup id=\"cite_ref-fda.gov_9-1\" class=\"reference\"><a href=\"#cite_note-fda.gov-9\">&#91;9&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Issues\">Issues</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Breakthrough_therapy&amp;action=edit&amp;section=3\" title=\"Edit section: Issues\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Critics have said that the name is misleading and provides companies that obtain a breakthrough designation for a drug candidate with a marketing advantage that may be undeserved.<sup id=\"cite_ref-JAMAIM_10-0\" class=\"reference\"><a href=\"#cite_note-JAMAIM-10\">&#91;10&#93;</a></sup> The FDA acknowledges that the name \"breakthrough therapy\" may be misleading. It was never meant to imply that these drugs are actually \u201cbreakthroughs,\u201d and it does not ensure that they will provide clinical benefit, but still critics complain that they are based on preliminary evidence, including changes in surrogate markers such as laboratory measurements, that often don't reflect \"meaningful clinical benefit.\"<sup id=\"cite_ref-healthnews_3-1\" class=\"reference\"><a href=\"#cite_note-healthnews-3\">&#91;3&#93;</a></sup>\nThe FDA guidance states: \"Not all products designated as breakthrough therapies ultimately will be shown to have the substantial improvement over available therapies suggested by the preliminary clinical evidence at the time of designation.  If the designation is no longer supported by subsequent data, FDA may rescind the designation.\"<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Breakthrough_therapy&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/List_of_drugs_granted_breakthrough_therapy_designation\" title=\"List of drugs granted breakthrough therapy designation\">List of drugs granted breakthrough therapy designation</a></li>\n<li><a href=\"/wiki/FDA_Fast_Track_Development_Program\" class=\"mw-redirect\" title=\"FDA Fast Track Development Program\">FDA Fast Track Development Program</a></li>\n<li><a href=\"/wiki/Priority_review_(FDA)\" class=\"mw-redirect\" title=\"Priority review (FDA)\">Priority review (FDA)</a></li>\n<li><a href=\"/wiki/Orphan_drug\" title=\"Orphan drug\">Orphan drug</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Breakthrough_therapy&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Darrow, JJ; Avorn, J; Kesselheim, AS (27 March 2014). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nejm.org/doi/full/10.1056/NEJMhle1311493\">\"New FDA breakthrough-drug category\u2014implications for patients\"</a>. <i>The New England Journal of Medicine</i>. <b>370</b> (13): 1252\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/nejmhle1311493\">10.1056/nejmhle1311493</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/24670173\">24670173</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=New+FDA+breakthrough-drug+category%E2%80%94implications+for+patients.&amp;rft.volume=370&amp;rft.issue=13&amp;rft.pages=1252-8&amp;rft.date=2014-03-27&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmhle1311493&amp;rft_id=info%3Apmid%2F24670173&amp;rft.aulast=Darrow&amp;rft.aufirst=JJ&amp;rft.au=Avorn%2C+J&amp;rft.au=Kesselheim%2C+AS&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMhle1311493&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Yandell, Kate (1 January 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.the-scientist.com/?articles.view/articleNo/44773/title/Picking-Up-the-Pace/\">\"Picking Up the Pace\"</a>. <i>The Scientist</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Scientist&amp;rft.atitle=Picking+Up+the+Pace&amp;rft.date=2016-01-01&amp;rft.aulast=Yandell&amp;rft.aufirst=Kate&amp;rft_id=http%3A%2F%2Fwww.the-scientist.com%2F%3Farticles.view%2FarticleNo%2F44773%2Ftitle%2FPicking-Up-the-Pace%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-healthnews-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-healthnews_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-healthnews_3-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Schwitzer G (13 May 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/\">\"CBS proclaims 'cancer breakthrough' \u2013 doesn't explain what FDA means by that term\"</a>. <i>Health News Review</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Health+News+Review&amp;rft.atitle=CBS+proclaims+%27cancer+breakthrough%27+%E2%80%93+doesn%27t+explain+what+FDA+means+by+that+term&amp;rft.date=2016-05-13&amp;rft.aulast=Schwitzer&amp;rft.aufirst=G&amp;rft_id=http%3A%2F%2Fwww.healthnewsreview.org%2F2016%2F05%2Fcbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid25713472-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid25713472_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid25713472_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-pmid25713472_4-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kepplinger EE (February 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266\">\"FDA's Expedited Approval Mechanisms for New Drug Products\"</a>. <i>Biotechnol Law Rep</i>. <b>34</b> (1): 15\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1089/blr.2015.9999\">10.1089/blr.2015.9999</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266\">4326266</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/25713472\">25713472</a>. <q>The fourth expedited approval mechanism\u2014the Breakthrough Therapy designation\u2014applies to a new drug product if it \"is intended, alone or in combination with 1 or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on 1 or more clinically significant endpoints.\"<sup>172</sup> In its Final Guidance, FDA has interpreted \"preliminary clinical evidence\" to mean evidence \"sufficient to indicate that the drug may demonstrate substantial improvement in effectiveness or safety over available therapies, but in most cases is not sufficient to establish safety and effectiveness for purposes of approval.\"<sup>173</sup> This generally will require more than data from in vitro studies or animal models.<sup>174</sup> FDA expects preliminary clinical evidence to come from Phase 1 or 2 clinical trials.<sup>175</sup></q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biotechnol+Law+Rep&amp;rft.atitle=FDA%27s+Expedited+Approval+Mechanisms+for+New+Drug+Products&amp;rft.volume=34&amp;rft.issue=1&amp;rft.pages=15-37&amp;rft.date=2015-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4326266&amp;rft_id=info%3Apmid%2F25713472&amp;rft_id=info%3Adoi%2F10.1089%2Fblr.2015.9999&amp;rft.aulast=Kepplinger&amp;rft.aufirst=EE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4326266&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-FDA_2012-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-FDA_2012_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-FDA_2012_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm\">\"Fact Sheet: Breakthrough Therapies\"</a>. United States Food and Drug Administration. 10 December 2014. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20171009081511/https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm\">Archived</a> from the original on 9 October 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>. <q>A breakthrough therapy is a drug:<br />&#160;&#8226;&#32;intended alone or in combination with one or more other drugs to treat a serious or life threatening disease or condition and<br />&#160;&#8226;&#32;preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.</q></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fact+Sheet%3A+Breakthrough+Therapies&amp;rft.pub=United+States+Food+and+Drug+Administration&amp;rft.date=2014-12-10&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2FRegulatoryInformation%2FLawsEnforcedbyFDA%2FSignificantAmendmentstotheFDCAct%2FFDASIA%2Fucm329491.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm341027.htm\">http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm341027.htm</a></span>\n</li>\n<li id=\"cite_note-FDASIA_2015-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-FDASIA_2015_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20150718082406/http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/\"><i>Food and Drug Administration Safety and Innovation Act (FDASIA)</i></a>, Silver Spring, MD: <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>, 29 January 2015, archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/\">the original</a> on 18 July 2015<span class=\"reference-accessdate\">, retrieved <span class=\"nowrap\">20 July</span> 2015</span></cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Food+and+Drug+Administration+Safety+and+Innovation+Act+%28FDASIA%29&amp;rft.place=Silver+Spring%2C+MD&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2015-01-29&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FRegulatoryInformation%2FLegislation%2FFederalFoodDrugandCosmeticActFDCAct%2FSignificantAmendmentstotheFDCAct%2FFDASIA%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Research, Center for Drug Evaluation and. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/INDActivityReports/ucm373559.htm\">\"IND Activity Reports - Breakthrough Therapy Designation Requests\"</a>. <i>www.fda.gov</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.fda.gov&amp;rft.atitle=IND+Activity+Reports+-+Breakthrough+Therapy+Designation+Requests&amp;rft.aulast=Research&amp;rft.aufirst=Center+for+Drug+Evaluation+and&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FDrugs%2FDevelopmentApprovalProcess%2FHowDrugsareDevelopedandApproved%2FDrugandBiologicApprovalReports%2FINDActivityReports%2Fucm373559.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-fda.gov-9\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-fda.gov_9-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-fda.gov_9-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm358301.pdf\">http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm358301.pdf</a></span>\n</li>\n<li id=\"cite_note-JAMAIM-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-JAMAIM_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Joseph S. Ross; Rita F. Redberg (21 September 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://archinte.jamanetwork.com/article.aspx?articleID=2442501\">\"Editor's Note: Would a Breakthrough Therapy by Any Other Name Be as Promising?\"</a>. <i>JAMA Intern. Med</i>. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jamainternmed.2015.5311\">10.1001/jamainternmed.2015.5311</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Intern.+Med.&amp;rft.atitle=Editor%27s+Note%3A+Would+a+Breakthrough+Therapy+by+Any+Other+Name+Be+as+Promising%3F&amp;rft.date=2015-09-21&amp;rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2015.5311&amp;rft.au=Joseph+S.+Ross&amp;rft.au=Rita+F.+Redberg&amp;rft_id=http%3A%2F%2Farchinte.jamanetwork.com%2Farticle.aspx%3FarticleID%3D2442501&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf\">\"Guidance for Industry Expedited Programs for Serious Conditions \u2013 Drugs and Biologics\"</a> <span style=\"font-size:85%;\">(PDF)</span>. FDA. May 2014. p.&#160;10.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guidance+for+Industry+Expedited+Programs+for+Serious+Conditions+%E2%80%93+Drugs+and+Biologics&amp;rft.pages=10&amp;rft.pub=FDA&amp;rft.date=2014-05&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2FUCM358301.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABreakthrough+therapy\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"23x15px&amp;#124;border_&amp;#124;alt=United_States&amp;#124;link=United_States_Pharmaceutical_industry_in_the_United_States\" style=\"padding:3px\"><table class=\"nowraplinks hlist collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pharmaceutical_industry_in_the_United_States\" title=\"Template:Pharmaceutical industry in the United States\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pharmaceutical_industry_in_the_United_States\" title=\"Template talk:Pharmaceutical industry in the United States\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Pharmaceutical_industry_in_the_United_States&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"23x15px&amp;#124;border_&amp;#124;alt=United_States&amp;#124;link=United_States_Pharmaceutical_industry_in_the_United_States\" style=\"font-size:114%;margin:0 4em\"><span class=\"flagicon\"><a href=\"/wiki/United_States\" title=\"United States\"><img alt=\"United States\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/a/a4/Flag_of_the_United_States.svg/23px-Flag_of_the_United_States.svg.png\" width=\"23\" height=\"12\" class=\"thumbborder\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/a/a4/Flag_of_the_United_States.svg/35px-Flag_of_the_United_States.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/a/a4/Flag_of_the_United_States.svg/46px-Flag_of_the_United_States.svg.png 2x\" data-file-width=\"1235\" data-file-height=\"650\" /></a></span> Pharmaceutical industry in the United States</div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Companies</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Abbott_Laboratories\" title=\"Abbott Laboratories\">Abbott Laboratories</a></li>\n<li><a href=\"/wiki/Acorda_Therapeutics\" title=\"Acorda Therapeutics\">Acorda Therapeutics</a></li>\n<li><a href=\"/wiki/Aderis_Pharmaceuticals\" title=\"Aderis Pharmaceuticals\">Aderis Pharmaceuticals</a></li>\n<li><a href=\"/wiki/Adolor_Corporation\" class=\"mw-redirect\" title=\"Adolor Corporation\">Adolor Corporation</a></li>\n<li><a href=\"/wiki/Alcon\" title=\"Alcon\">Alcon</a></li>\n<li><a href=\"/wiki/Alexion_Pharmaceuticals\" title=\"Alexion Pharmaceuticals\">Alexion Pharmaceuticals</a></li>\n<li><a href=\"/wiki/Alkermes_(company)\" title=\"Alkermes (company)\">Alkermes</a></li>\n<li><a href=\"/wiki/Allergan\" title=\"Allergan\">Allergan</a></li>\n<li><a href=\"/wiki/Alza\" class=\"mw-redirect\" title=\"Alza\">Alza</a></li>\n<li><a href=\"/wiki/Amgen\" title=\"Amgen\">Amgen</a></li>\n<li><a href=\"/wiki/Amylin_Pharmaceuticals\" title=\"Amylin Pharmaceuticals\">Amylin Pharmaceuticals</a></li>\n<li><a href=\"/wiki/ARIAD_Pharmaceuticals\" title=\"ARIAD Pharmaceuticals\">ARIAD Pharmaceuticals</a></li>\n<li><a href=\"/wiki/Avax_Technologies\" title=\"Avax Technologies\">Avax Technologies</a></li>\n<li><b><a href=\"/wiki/Template:Pharmaceutical_companies_of_the_United_States\" title=\"Template:Pharmaceutical companies of the United States\">more...</a></b></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Regulatory bodies</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Professional bodies</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/American_Pharmacists_Association\" title=\"American Pharmacists Association\">American Pharmacists Association</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Miscellaneous</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Contract_research_organization\" title=\"Contract research organization\">Contract research organization</a></li>\n<li><a href=\"/wiki/Clinical_research_associate\" title=\"Clinical research associate\">Clinical research associate</a></li>\n<li><a href=\"/wiki/Drug_rep\" class=\"mw-redirect\" title=\"Drug rep\">Drug rep</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry\" title=\"Pharmaceutical industry\">Pharmaceutical industry</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_Bangladesh\" title=\"Pharmaceutical industry in Bangladesh\">in Bangladesh</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_India\" title=\"Pharmaceutical industry in India\">in India</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_the_People%27s_Republic_of_China\" class=\"mw-redirect\" title=\"Pharmaceutical industry in the People&#39;s Republic of China\">in China</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_Pakistan\" title=\"Pharmaceutical industry in Pakistan\">in Pakistan</a></li>\n<li><a href=\"/wiki/Pharmaceutical_industry_in_the_United_Kingdom\" title=\"Pharmaceutical industry in the United Kingdom\">in the UK</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Books</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><i><a href=\"/wiki/The_Billion-Dollar_Molecule\" title=\"The Billion-Dollar Molecule\">The Billion-Dollar Molecule</a></i> (1994)</li>\n<li><i><a href=\"/wiki/Mad_in_America\" title=\"Mad in America\">Mad in America</a></i> (2002)</li>\n<li><i><a href=\"/wiki/Big_Pharma_(book)\" title=\"Big Pharma (book)\">Big Pharma</a></i> (2006)</li>\n<li><i><a href=\"/wiki/Side_Effects_(Bass_book)\" title=\"Side Effects (Bass book)\">Side Effects</a></i> (2008)</li>\n<li><i><a href=\"/wiki/Anatomy_of_an_Epidemic\" title=\"Anatomy of an Epidemic\">Anatomy of an Epidemic</a></i> (2010)</li>\n<li><i><a href=\"/wiki/Bad_Pharma\" title=\"Bad Pharma\">Bad Pharma</a></i> (2012)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Lists</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/List_of_drugs\" title=\"List of drugs\">List of drugs</a></li>\n<li><a href=\"/wiki/List_of_largest_pharmaceutical_settlements\" title=\"List of largest pharmaceutical settlements\">List of largest pharmaceutical settlements</a></li>\n<li><a href=\"/wiki/List_of_off-label_promotion_pharmaceutical_settlements\" title=\"List of off-label promotion pharmaceutical settlements\">List of off-label promotion pharmaceutical settlements</a></li>\n<li><a href=\"/wiki/List_of_pharmaceutical_companies\" title=\"List of pharmaceutical companies\">List of pharmaceutical companies</a></li>\n<li><a href=\"/wiki/List_of_pharmaceutical_manufacturers_in_the_United_Kingdom\" title=\"List of pharmaceutical manufacturers in the United Kingdom\">List of pharmaceutical manufacturers in the UK</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Related templates</th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Template:Pharmaceutical_industry_by_country\" title=\"Template:Pharmaceutical industry by country\">Pharmaceutical industry by country</a></li>\n<li><a href=\"/wiki/Template:Pharmaceutical_industry_in_the_United_Kingdom\" class=\"mw-redirect\" title=\"Template:Pharmaceutical industry in the United Kingdom\">in the UK</a></li>\n<li><a href=\"/wiki/Template:Pharmaceutical_companies_of_the_United_States\" title=\"Template:Pharmaceutical companies of the United States\">of the US</a></li>\n<li><a href=\"/wiki/Template:Medicine\" title=\"Template:Medicine\">Medicine</a></li>\n<li><a href=\"/wiki/Template:Public_health\" title=\"Template:Public health\">Public health</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%;text-align: left;\">Related categories</th><td class=\"navbox-list navbox-even\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Category:Pharmaceutical_companies_of_the_United_States\" title=\"Category:Pharmaceutical companies of the United States\">Pharmaceutical companies of the United States</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_Australia\" title=\"Category:Pharmaceutical companies of Australia\">of Australia</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_Canada\" title=\"Category:Pharmaceutical companies of Canada\">of Canada</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_Finland\" title=\"Category:Pharmaceutical companies of Finland\">of Finland</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_India\" title=\"Category:Pharmaceutical companies of India\">of India</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_Japan\" title=\"Category:Pharmaceutical companies of Japan\">of Japan</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_Switzerland\" title=\"Category:Pharmaceutical companies of Switzerland\">of Switzerland</a></li>\n<li><a href=\"/wiki/Category:Pharmaceutical_companies_of_the_United_Kingdom\" title=\"Category:Pharmaceutical companies of the United Kingdom\">of the UK</a></li></ul>\n</div></td></tr><tr><td class=\"navbox-abovebelow\" colspan=\"2\"><div><img alt=\"Category\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/16px-Folder_Hexagonal_Icon.svg.png\" title=\"Category\" width=\"16\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/24px-Folder_Hexagonal_Icon.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/48/Folder_Hexagonal_Icon.svg/32px-Folder_Hexagonal_Icon.svg.png 2x\" data-file-width=\"36\" data-file-height=\"31\" /> <b><a href=\"/wiki/Category:Pharmaceutical_industry_in_the_United_States\" title=\"Category:Pharmaceutical industry in the United States\">Category</a></b></div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw2164\nCached time: 20180918004956\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.328 seconds\nReal time usage: 0.378 seconds\nPreprocessor visited node count: 758/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 41408/2097152 bytes\nTemplate argument size: 308/2097152 bytes\nHighest expansion depth: 12/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 15801/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.111/10.000 seconds\nLua memory usage: 2.88 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  303.132      1 -total\n 65.04%  197.159      1 Template:Reflist\n 22.61%   68.537      3 Template:Cite_journal\n 15.43%   46.772      1 Template:Pharmaceutical_industry_in_the_United_States\n 14.35%   43.501      1 Template:Navbox\n 12.80%   38.788      1 Template:Use_dmy_dates\n  7.70%   23.350      3 Template:Cite_web\n  5.56%   16.850      1 Template:DMCA\n  5.29%   16.031      2 Template:Cite_news\n  4.65%   14.110      1 Template:Dated_maintenance_category\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:45597229-0!canonical and timestamp 20180918004955 and revision id 848731119\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Use_dmy_dates_from_October_2017"},{"sortkey":"","*":"Pharmacy"},{"sortkey":" ","*":"Breakthrough_therapy"}],"links":[{"ns":14,"exists":"","*":"Category:Use dmy dates from October 2017"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of Australia"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of Canada"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of Finland"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of India"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of Japan"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of Switzerland"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of the United Kingdom"},{"ns":14,"exists":"","*":"Category:Pharmaceutical companies of the United States"},{"ns":14,"exists":"","*":"Category:Pharmaceutical industry in the United States"},{"ns":0,"exists":"","*":"United States"},{"ns":0,"exists":"","*":"ARIAD Pharmaceuticals"},{"ns":0,"exists":"","*":"Abbott Laboratories"},{"ns":0,"exists":"","*":"Accelerated approval (FDA)"},{"ns":0,"exists":"","*":"Acorda Therapeutics"},{"ns":0,"exists":"","*":"Aderis Pharmaceuticals"},{"ns":0,"exists":"","*":"Adolor Corporation"},{"ns":0,"exists":"","*":"Alcon"},{"ns":0,"exists":"","*":"Alexion Pharmaceuticals"},{"ns":0,"exists":"","*":"Alkermes (company)"},{"ns":0,"exists":"","*":"Allergan"},{"ns":0,"exists":"","*":"Alza"},{"ns":0,"exists":"","*":"American Pharmacists Association"},{"ns":0,"exists":"","*":"Amgen"},{"ns":0,"exists":"","*":"Amylin Pharmaceuticals"},{"ns":0,"exists":"","*":"Anatomy of an Epidemic"},{"ns":0,"exists":"","*":"Avax Technologies"},{"ns":0,"exists":"","*":"Bad Pharma"},{"ns":0,"exists":"","*":"Big Pharma (book)"},{"ns":0,"exists":"","*":"Center for Biologics Evaluation and Research"},{"ns":0,"exists":"","*":"Center for Drug Evaluation and Research"},{"ns":0,"exists":"","*":"Clinical research associate"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Combination therapy"},{"ns":0,"exists":"","*":"Contract research organization"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Drug rep"},{"ns":0,"exists":"","*":"FDA Fast Track Development Program"},{"ns":0,"exists":"","*":"Fast track (FDA)"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Food and Drug Administration Safety and Innovation Act"},{"ns":0,"exists":"","*":"Investigational new drug"},{"ns":0,"exists":"","*":"List of drugs"},{"ns":0,"exists":"","*":"List of drugs granted breakthrough therapy designation"},{"ns":0,"exists":"","*":"List of largest pharmaceutical settlements"},{"ns":0,"exists":"","*":"List of off-label promotion pharmaceutical settlements"},{"ns":0,"exists":"","*":"List of pharmaceutical companies"},{"ns":0,"exists":"","*":"List of pharmaceutical manufacturers in the United Kingdom"},{"ns":0,"exists":"","*":"Mad in America"},{"ns":0,"exists":"","*":"Orphan drug"},{"ns":0,"exists":"","*":"Pharmaceutical industry"},{"ns":0,"exists":"","*":"Pharmaceutical industry in Bangladesh"},{"ns":0,"exists":"","*":"Pharmaceutical industry in India"},{"ns":0,"exists":"","*":"Pharmaceutical industry in Pakistan"},{"ns":0,"exists":"","*":"Pharmaceutical industry in the People's Republic of China"},{"ns":0,"exists":"","*":"Pharmaceutical industry in the United Kingdom"},{"ns":0,"exists":"","*":"Priority review (FDA)"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Side Effects (Bass book)"},{"ns":0,"exists":"","*":"The Billion-Dollar Molecule"},{"ns":10,"exists":"","*":"Template:Pharmaceutical industry in the United States"},{"ns":10,"exists":"","*":"Template:Medicine"},{"ns":10,"exists":"","*":"Template:Pharmaceutical companies of the United States"},{"ns":10,"exists":"","*":"Template:Pharmaceutical industry by country"},{"ns":10,"exists":"","*":"Template:Pharmaceutical industry in the United Kingdom"},{"ns":10,"exists":"","*":"Template:Public health"},{"ns":11,"exists":"","*":"Template talk:Pharmaceutical industry in the United States"}],"templates":[{"ns":10,"exists":"","*":"Template:Use dmy dates"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Bull"},{"ns":10,"exists":"","*":"Template:\u2022"},{"ns":10,"exists":"","*":"Template:Citation"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Pharmaceutical industry in the United States"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Flagicon"},{"ns":10,"exists":"","*":"Template:Country data United States"},{"ns":10,"exists":"","*":"Template:Flagicon/core"},{"ns":10,"exists":"","*":"Template:Icon"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Icon"},{"ns":828,"exists":"","*":"Module:Icon/data"}],"images":["Lock-green.svg","Flag_of_the_United_States.svg","Folder_Hexagonal_Icon.svg"],"externallinks":["http://www.nejm.org/doi/full/10.1056/NEJMhle1311493","//doi.org/10.1056/nejmhle1311493","//www.ncbi.nlm.nih.gov/pubmed/24670173","http://www.the-scientist.com/?articles.view/articleNo/44773/title/Picking-Up-the-Pace/","http://www.healthnewsreview.org/2016/05/cbs-proclaims-cancer-breakthrough-doesnt-explain-what-fda-means-by-that-term/","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4326266","//doi.org/10.1089/blr.2015.9999","//www.ncbi.nlm.nih.gov/pubmed/25713472","https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm","https://web.archive.org/web/20171009081511/https://www.fda.gov/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/ucm329491.htm","https://web.archive.org/web/20150718082406/http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/","http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/","http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/INDActivityReports/ucm373559.htm","http://archinte.jamanetwork.com/article.aspx?articleID=2442501","//doi.org/10.1001/jamainternmed.2015.5311","http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf","http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FDASIA/ucm341027.htm","http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm358301.pdf"],"sections":[{"toclevel":1,"level":"2","line":"Requirements","number":"1","index":"1","fromtitle":"Breakthrough_therapy","byteoffset":4344,"anchor":"Requirements"},{"toclevel":1,"level":"2","line":"Incentives","number":"2","index":"2","fromtitle":"Breakthrough_therapy","byteoffset":6519,"anchor":"Incentives"},{"toclevel":1,"level":"2","line":"Issues","number":"3","index":"3","fromtitle":"Breakthrough_therapy","byteoffset":6831,"anchor":"Issues"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Breakthrough_therapy","byteoffset":8442,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Breakthrough_therapy","byteoffset":8604,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Breakthrough therapy","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q25326544"}]}}